Myeloproliferative Neoplasms News

CHICAGO — ASCO’s big-data initiative CancerLinQ announced a long-term partnership with the FDA to use patient data to evaluate the real-world use of newly approved cancer therapies, according to a press release.

National Cancer Survivors Day, recognized annually on the first Sunday in June, provides free education and networking to hospitals, support groups and other cancer-related organizations to help improve the quality of life of cancer survivors.

Michael A. Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center, took over this spring as president of American Association for Cancer Research.

A reduced-intensity conditioning regimen yielded comparable RFS and OS as standard myeloablative conditioning among patients with myelodysplastic syndrome, according to results of the phase 3 RICMAC clinical trial.

Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood cancers, thus limiting referrals, according to study results published in Cancer.

Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in CA: A Cancer Journal for Clinicians.

Two medical students received the 2017-2018 ASH Physician–Scientist Career Development Award.

Patients continue to face a “tsunami” of financial burdens associated with cancer care, but advances in immunotherapy and precision medicine offer much promise, according to participants of a roundtable discussion hosted by The Leukemia & Lymphoma Society.

The FDA approved midostaurin as part of combination treatment for adults with newly diagnosed FLT3–positive acute myeloid leukemia.

The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer.